Literature DB >> 11214383

DNA patents and scientific discovery and innovation: assessing benefits and risks.

D B Resnik1.   

Abstract

This paper focuses on the question of whether DNA patents help or hinder scientific discovery and innovation. While DNA patents create a wide variety of possible benefits and harms for science and technology, the evidence we have at this point in time supports the conclusion that they will probably promote rather than hamper scientific discovery and innovation. However, since DNA patenting is a relatively recent phenomena and the biotechnology industry is in its infancy, we should continue to gather evidence about the effects of DNA patenting on scientific innovation and discovery as well the economic, social, and legal conditions relating to intellectual property in biotechnology. We should give the free market, the courts, researchers, and patent offices a chance to settle issues related to innovation and discovery, before we seek legislative remedies, since new laws proposed at this point would lack adequate foresight and could do more harm than good. However, we should be open to new laws or regulations on DNA patents if they are required to in order to deal with some of the biases and limitations of the free market.

Entities:  

Keywords:  Biomedical and Behavioral Research; Genetics and Reproduction

Mesh:

Substances:

Year:  2001        PMID: 11214383     DOI: 10.1007/s11948-001-0023-9

Source DB:  PubMed          Journal:  Sci Eng Ethics        ISSN: 1353-3452            Impact factor:   3.525


  42 in total

1.  A high-stakes gamble on genome sequencing.

Authors:  E Marshall
Journal:  Science       Date:  1999-06-18       Impact factor: 47.728

2.  Gene patent race speeds ahead amid controversy, concern.

Authors:  T Reynolds
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

3.  Biomedical patents. Patent office may raise the bar on gene claims.

Authors:  M Enserink
Journal:  Science       Date:  2000-02-18       Impact factor: 47.728

4.  Biotech patents. Genentech, UC settle suit for $200 million.

Authors:  M Barinaga
Journal:  Science       Date:  1999-11-26       Impact factor: 47.728

5.  Evaluation of conflict of interest in economic analyses of new drugs used in oncology.

Authors:  M Friedberg; B Saffran; T J Stinson; W Nelson; C L Bennett
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

6.  Agricultural biotechnology. Monsanto donates its share of golden rice.

Authors:  D Normile
Journal:  Science       Date:  2000-08-11       Impact factor: 47.728

7.  Disease genes are not patentable: a rebuttal of McGee.

Authors:  J F Merz; M K Cho
Journal:  Camb Q Healthc Ethics       Date:  1998       Impact factor: 1.284

8.  Trends and patterns in research and development expenditures in the United States.

Authors:  A B Jaffe
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

9.  Coming to grips with genes and risk.

Authors:  P Kahn
Journal:  Science       Date:  1996-10-25       Impact factor: 47.728

10.  Trends in biological research. Big-time biology.

Authors:  T Beardsley
Journal:  Sci Am       Date:  1994-11       Impact factor: 2.142

View more
  7 in total

1.  Genes in court.

Authors:  R Spier
Journal:  Sci Eng Ethics       Date:  2001-01       Impact factor: 3.525

2.  The commercialization of human stem cells: ethical and policy issues.

Authors:  David B Resnik
Journal:  Health Care Anal       Date:  2002

3.  Ethico-legal issues in biomedicine patenting: a patent professional viewpoint.

Authors:  R Stephen Crespi
Journal:  Sci Eng Ethics       Date:  2005-01       Impact factor: 3.525

4.  Shackling the shoulders of giants. A report on excerpts from the National Academies' Symposium on the Role of Scientific and Technical Data and Information in the Public Domain, Washington, DC, September 5-6, 2002.

Authors:  John S Gardenier
Journal:  Sci Eng Ethics       Date:  2003-07       Impact factor: 3.525

5.  Ethical reasons for narrowing the scope of biotech patents.

Authors:  Tom Andreassen
Journal:  Med Health Care Philos       Date:  2015-11

Review 6.  Whole-genome patenting.

Authors:  Maureen A O'Malley; Adam Bostanci; Jane Calvert
Journal:  Nat Rev Genet       Date:  2005-06       Impact factor: 53.242

7.  Effects of research tool patents on biotechnology innovation in a developing country: a case study of South Korea.

Authors:  Kyung-Nam Kang; Tae-Kyu Ryu; Yoon-Sik Lee
Journal:  BMC Biotechnol       Date:  2009-03-26       Impact factor: 2.563

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.